You just read:

Dragonfly Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel Natural Killer (NK) Cell-Based Immunotherapies using Dragonfly's TriNKET™ technology platform

News provided by

Dragonfly Therapeutics, Inc.

Jun 12, 2017, 09:02 ET